Search Results - "Andrew A Moshfeghi"

Quantitative microvascular analysis of retinal venous occlusions by spectral domain optical coherence tomography angiography by Koulisis, Nicole, Kim, Alice Y, Chu, Zhongdi, Shahidzadeh, Anoush, Burkemper, Bruce, Olmos de Koo, Lisa C, Moshfeghi, Andrew A, Ameri, Hossein, Puliafito, Carmen A, Isozaki, Veronica L, Wang, Ruikang K, Kashani, Amir H

“…To quantitatively evaluate the retinal microvasculature in human subjects with retinal venous occlusions (RVO) using optical coherence tomography angiography…”
Get full text

The Epidemiology of Retinopathy of Prematurity in the United States by Ludwig, Cassie A, Chen, Tiffany A, Hernandez-Boussard, Tina, Moshfeghi, Andrew A, Moshfeghi, Darius M

“…Retinopathy of prematurity (ROP) is a leading cause of blindness in premature and low birth weight infants. Here, the authors examine the incidence of ROP in…”
Get more information

Impact of anti-VEGF treatment on development of proliferative diabetic retinopathy in routine clinical practice by Moshfeghi, Andrew A, Khurana, Rahul N, Moini, Hadi, Sherman, Steven, Reed, Kimberly, Boucher, Nick, Rahimy, Ehsan

“…This study evaluated impact of anti-vascular endothelial growth factor (VEGF) treatment on proliferative diabetic retinopathy (PDR) development among patients…”
Get full text

Optical coherence tomography findings after an intravitreal injection of bevacizumab (avastin) for neovascular age-related macular degeneration by Rosenfeld, Philip J, Moshfeghi, Andrew A, Puliafito, Carmen A

“…To determine whether intravitreal bevacizumab could improve optical coherence tomography and visual acuity outcomes in a patient with neovascular age-related…”
Get more information

Eye-related Emergency Department Visits in the United States, 2010 by Vaziri, Kamyar, MD, Schwartz, Stephen G., MD, MBA, Flynn, Harry W., MD, Kishor, Krishna S., MD, Moshfeghi, Andrew A., MD, MBA

Get full text

Capillary density and caliber as assessed by optical coherence tomography angiography may be significant predictors of diabetic retinopathy severity by Kushner-Lenhoff, Sam, Kogachi, Kaitlin, Mert, Melissa, Chu, Zhongdi, Shahidzadeh, Anoush, Palejwala, Neal V, Wolfe, Jeremy, Itty, Sujit, Drenser, Kimberly A, Capone, Jr, Antonio, Dugel, Pravin U, Moshfeghi, Andrew A, Ameri, Hossein, Daskivich, Lauren P, Wang, Ruikang K, Kashani, Amir H

“…To validate retinal capillary density and caliber associations with diabetic retinopathy (DR) severity in different clinical settings. This cross-sectional…”
Get full text

Mining Retrospective Data for Virtual Prospective Drug Repurposing: L-DOPA and Age-related Macular Degeneration by Brilliant, Murray H., PhD, Vaziri, Kamyar, MD, Connor, Thomas B., MD, Schwartz, Stephen G., MD, MBA, Carroll, Joseph J., PhD, McCarty, Catherine A., PhD, MPH, Schrodi, Steven J., PhD, Hebbring, Scott J., PhD, Kishor, Krishna S., MD, Flynn, Harry W., MD, Moshfeghi, Andrew A., MD, Moshfeghi, Darius M., MD, Fini, M. Elizabeth, PhD, McKay, Brian S., PhD

“…Abstract Background Age-related macular degeneration (AMD) is a leading cause of visual loss among the elderly. A key cell type involved in AMD, the retinal…”
Get full text

Rates of Reoperation and Retinal Detachment after Macular Hole Surgery by Vaziri, Kamyar, MD, Schwartz, Stephen G., MD, MBA, Kishor, Krishna S., MD, Fortun, Jorge A., MD, Moshfeghi, Andrew A., MD, MBA, Smiddy, William E., MD, Flynn, Harry W., MD

“…Purpose To evaluate rates of reoperation and retinal detachment (RD) after macular hole surgery. Design Retrospective cross-sectional study. Participants…”
Get full text

Current Infectious Endophthalmitis Rates After Intravitreal Injections of Anti-Vascular Endothelial Growth Factor Agents and Outcomes of Treatment by Gregori, Ninel Z, Flynn, Jr, Harry W, Schwartz, Stephen G, Rosenfeld, Philip J, Vaziri, Kamyar, Moshfeghi, Andrew A, Fortun, Jorge A, Kovach, Jaclyn L, Dubovy, Sander R, Albini, Thomas A, Davis, Janet L, Berrocal, Audina M, Smiddy, William E

“…To assess the incidence and outcomes of infectious endophthalmitis after intravitreal injections of anti-vascular endothelial growth factor (anti-VEGF) agents…”
Get more information

Simulation of long-term impact of intravitreal anti-VEGF therapy on patients with severe non-proliferative diabetic retinopathy by Nguyen, Quan Dong, Moshfeghi, Andrew A, Lim, Jennifer I, Ponomareva, Ekaterina, Chauhan, Ankita, Rao, Rohini, Sherman, Steven

“…ObjectiveA simulation model was constructed to assess long-term outcomes of proactively treating severe non-proliferative diabetic retinopathy (NPDR) with…”
Get full text

Self-Reported Characteristics of Retina Specialists in the United States by Kim, Esther Lee, MD, Tran, Jeffrey S., BA, Moshfeghi, Andrew A., MD, MBA

Get full text

Local ischemia and increased expression of vascular endothelial growth factor following ocular dissemination of Mycobacterium tuberculosis by Thayil, Seema M, Albini, Thomas A, Nazari, Hossein, Moshfeghi, Andrew A, Parel, Jean-Marie A, Rao, Narsing A, Karakousis, Petros C

“…The pathogenesis of intraocular tuberculosis remains poorly understood partly due to the lack of adequate animal models that accurately simulate human disease…”
Get full text

Ambulatory surgery center utilization by vitreoretinal surgeons: 1999-2011 by Vaziri, Kamyar, Moshfeghi, Darius M, Hernandez-Boussard, Tina, Callaway, Natalia F, Moshfeghi, Andrew A

“…To evaluate the utilization rates of ambulatory surgery centers (ASCs) in the state of Florida for vitreoretinal, cataract, and glaucoma surgical procedures…”
Get more information

Association Between Growth of Geographic Atrophy and the Complement Factor I Locus by Yehoshua, Zohar, de Amorim Garcia Filho, Carlos Alexandre, Nunes, Renata Portella, Gregori, Giovanni, Penha, Fernando M, Moshfeghi, Andrew A, Luo, Hongrong, Kang, Zhang, Sadda, SriniVas, Feuer, William, Rosenfeld, Philip J

“…The association between the growth of geographic atrophy (GA) and a single nucleotide polymorphism (SNP) in the complement factor I (CFI) locus was…”
Get more information

Systemic complement inhibition with eculizumab for geographic atrophy in age-related macular degeneration: the COMPLETE study by Yehoshua, Zohar, de Amorim Garcia Filho, Carlos Alexandre, Nunes, Renata Portella, Gregori, Giovanni, Penha, Fernando M, Moshfeghi, Andrew A, Zhang, Kang, Sadda, Srinivas, Feuer, William, Rosenfeld, Philip J

“…To evaluate the effect of eculizumab, a systemic inhibitor of complement component (C5), on the growth of geographic atrophy (GA) in patients with age-related…”
Get full text

Risk Factors Predictive of Endogenous Endophthalmitis Among Hospitalized Patients With Hematogenous Infections in the United States by Vaziri, Kamyar, Pershing, Suzann, Albini, Thomas A, Moshfeghi, Darius M, Moshfeghi, Andrew A

“…Purpose To identify potential risk factors associated with endogenous endophthalmitis among hospitalized patients with hematogenous infections. Design…”
Get full text

Factors associated with diabetic macular edema in patients with proliferative diabetic retinopathy by O’Fee, John R., Juliano, Joseph, Moshfeghi, Andrew A.

“…Purpose To identify factors associated with diabetic macular edema (DME) and to characterize the types of DME present in eyes with proliferative diabetic…”
Get full text

Systemic Complement Inhibition with Eculizumab for Geographic Atrophy in Age-Related Macular Degeneration by Yehoshua, Zohar, MD, MHA, Alexandre de Amorim Garcia Filho, Carlos, MD, Nunes, Renata Portella, MD, Gregori, Giovanni, PhD, Penha, Fernando M., MD, PhD, Moshfeghi, Andrew A., MD, MBA, Zhang, Kang, MD, PhD, Sadda, SriniVas, MD, Feuer, William, MS, Rosenfeld, Philip J., MD, PhD

“…Purpose To evaluate the effect of eculizumab, a systemic inhibitor of complement component (C5), on the growth of geographic atrophy (GA) in patients with…”
Get full text

Social Cost of Blindness Due to AMD and Diabetic Retinopathy in the United States in 2020 by Moshfeghi, Andrew A, Lanitis, Tereza, Kropat, Georg, Kuznik, Andreas, Gibson, Andrea, Feng, Haidong, Prenner, Jonathan

“…To estimate the social cost of blindness due to wet age-related macular degeneration (wAMD), diabetic macular edema (DME), and proliferative diabetic…”
Get more information

LONG-TERM VISUAL OUTCOMES AND CLINICAL FEATURES AFTER ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR INJECTION-RELATED ENDOPHTHALMITIS by Rayess, Nadim, Obeid, Anthony, Storey, Philip P, Juliano, Joseph, Rahimy, Ehsan, Moshfeghi, Andrew A, Garg, Sunir, Hsu, Jason

“…To determine long-term visual outcomes in patients who developed endophthalmitis after intravitreal anti-vascular endothelial growth factor injections and to…”
Get full text